Why did the Government file a Topamax lawsuit?

Topamax manufacturers settled a $75million False Claim Act (also known as a qui tam provision).  The lawsuit alleged that although topamax was only approved by the FDA to treat epilepsy and preventing headaches, the medication was promoted for unapproved psychiatric uses.  Topamax’s manufacturers hired outside physicians to join sales representatives when they visited health care providers and spoke at meetings and dinners about prescribing Toopamax for psychiatric uses that were not approved by the FDA as safe and effective.

The information on this page is meant to provide a general overview of the law. The laws in your state and/or city may deviate significantly from those described here. If you have specific questions related to your situation you should speak with a local attorney.

Additional Topamax Articles

Search LawInfo's Topamax Resources